Shipley J M, Klinkenberg M, Wu B M, Bachinsky D R, Grubb J H, Sly W S
Edward A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, MO 63104.
Am J Hum Genet. 1993 Mar;52(3):517-26.
PCR of cDNA produced from patient fibroblasts allowed us to determine the paternal mutation in the first patient reported with beta-glucuronidase-deficiency mucopolysaccharidosis type VII (MPS VII). The G-->T transversion 1,881 bp downstream of the ATG translation initiation codon destroys an MboII restriction site and converts Trp627 to Cys (W627C). Digestion of genomic DNA PCR fragments with MboII indicated that the patient and the father were heterozygous for this missense mutation in exon 12. Failure to find cDNAs from patient RNA which did not contain this mutation suggested that the maternal mutation leads to greatly reduced synthesis or reduced stability of mRNA from the mutant allele. In order to identify the maternal mutation, it was necessary to analyze genomic sequences. This approach was complicated by the finding of multiple unprocessed pseudogenes and/or closely related genes. Using PCR with a panel of human/rodent hybrid cell lines, we found that these pseudogenes were present over chromosomes 5-7, 20, and 22 and the Y chromosome. Conditions were defined which allowed us to amplify and characterize genomic sequences for the true beta-glucuronidase gene despite this background of related sequences. The patient proved to be heterozygous for a second mutation, in which a C-->T transition introduces a termination codon (R356STOP) in exon 7. The mother was also heterozygous for this mutation. Expression of a cDNA containing the maternal mutation produced no enzyme activity, as expected. Expression of the paternal mutation in COS-7 cells produced a surprisingly high (65% of control) level of activity. However, activity was 13% of control in transiently transfected murine MPS VII cells. The level of activity of this mutant allele appears to correlate with the level of overexpression, suggesting that high concentrations of mutant monomers can drive the folding and tetramerization of mutant enzyme to produce an active and stable enzyme.
对患者成纤维细胞产生的cDNA进行聚合酶链反应(PCR),使我们能够确定首例报告的β-葡萄糖醛酸酶缺乏型黏多糖贮积症VII型(MPS VII)患者的父系突变。起始密码子ATG下游1881bp处的G→T颠换破坏了一个MboII限制性酶切位点,并将Trp627转变为Cys(W627C)。用MboII消化基因组DNA PCR片段表明,患者和父亲在第12外显子的这个错义突变上是杂合子。未能从不含该突变的患者RNA中找到cDNA,这表明母系突变导致突变等位基因的mRNA合成大幅减少或稳定性降低。为了鉴定母系突变,有必要分析基因组序列。由于发现了多个未加工的假基因和/或密切相关的基因,这种方法变得复杂。使用一组人/鼠杂交细胞系进行PCR,我们发现这些假基因存在于5 - 7号、20号和22号染色体以及Y染色体上。尽管存在相关序列背景,但我们确定了一些条件,使我们能够扩增并鉴定真正的β-葡萄糖醛酸酶基因的基因组序列。结果证明该患者在第二个突变上是杂合子,其中一个C→T转换在第7外显子中引入了一个终止密码子(R356STOP)。母亲在这个突变上也是杂合子。正如预期的那样,含有母系突变的cDNA的表达没有产生酶活性。父系突变在COS - 7细胞中的表达产生了令人惊讶的高活性水平(为对照的65%)。然而,在瞬时转染的小鼠MPS VII细胞中,活性仅为对照的13%。这个突变等位基因的活性水平似乎与过表达水平相关,这表明高浓度的突变单体可以驱动突变酶的折叠和四聚化,从而产生有活性且稳定的酶。